SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-08-001761
Filing Date
2008-04-02
Accepted
2008-04-02 15:21:15
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F c72862e20vf.htm 20-F 1802291
2 EXHIBIT 12.1 c72862exv12w1.htm EX-12.1 6455
3 EXHIBIT 12.2 c72862exv12w2.htm EX-12.2 6445
4 EXHIBIT 13.1 c72862exv13w1.htm EX-13.1 3574
5 EXHIBIT 13.2 c72862exv13w2.htm EX-13.2 3442
6 EXHIBIT 15.1 c72862exv15w1.htm EX-15.1 1984
  Complete submission text file 0001362310-08-001761.txt   1825663
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 08733204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances